Are You a Connected Cancer Patient? Tell the President's Cancer Panel What You Think!

Article

The President's Cancer Panel is looking for ways to improve connected health for cancer patients. What are your recommendations?

The President's Cancer Panel is looking for ways to improve connected health for cancer patients. What are your recommendations?

The President's Cancer Panel is looking for ways to improve connected health for cancer patients. What are your recommendations?

Like many cancer patients, you are part of connected health: By reading this blog, you are using technology like the Internet, computers and smartphones to access information about a disease or patient experience.

This year the President’s Cancer Panel workshop series is addressing various aspects of connected health. Their third workshop on July 9, titled The Connected Cancer Patient: Vision for the Future and Recommendations for Action, will be open to the public (see agenda and attendees).

Cancer patient advocates Corrie Painter, Stacey Tinianov and I will be participating in the July President’s Cancer Panel Workshop. To help gather input for the event, we will be guests on the Healthcare Leadership (#hcldr) tweetchat Tuesday, July 7, at 8:30 p.m. EDT. The questions we will be addressing are:

  • T1 What are critical unmet health care needs among patients and families that could be addressed with connected health approaches?
  • T2 How could connected health approaches promote patient activation and engagement, particularly in cancer?
  • T3 How can engaged patient communities be encouraged to contribute to health system reform? How might their role be formalized?
  • T4 What communication tools would help patients be more engaged in their care?

You can read more about the chat and connected cancer patients on the hcldr blog at The Connected Cancer Patient: Future Vision and Recommendations. There's a primer on participating in tweetchats on the #LCSM Chat website (just substitute the hashtag #hcldr for #lcsm in the instructions). I hope you’ll join us!

You can also leave your comments here. I will bring any comments left by 10 p.m. EDT July 8 with me to the workshop as input for the session.

Related Videos
For patients with cancer, the ongoing chemotherapy shortage may cause some anxiety as they wonder how they will receive their drugs. However, measuring drugs “down to the minutiae of the milligrams” helped patients receive the drugs they needed, said Alison Tray. Tray is an advanced oncology certified nurse practitioner and current vice president of ambulatory operations at Rutgers Cancer Institute in New Jersey.  If patients are concerned about getting their cancer drugs, Tray noted that having “an open conversation” between patients and providers is key.  “As a provider and a nurse myself, having that conversation, that reassurance and sharing the information is a two-way conversation,” she said. “So just knowing that we're taking care of you, we're going to make sure that you receive the care that you need is the key takeaway.” In June 2023, many patients were unable to receive certain chemotherapy drugs, such as carboplatin and cisplatin because of an ongoing shortage. By October 2023, experts saw an improvement, although the “ongoing crisis” remained.  READ MORE: Patients With Lung Cancer Face Unmet Needs During Drug Shortages “We’re really proud of the work that we could do and achieve that through a critical drug shortage,” Tray said. “None of our patients missed a dose of chemotherapy and we were able to provide that for them.” Tray sat down with CURE® during the 49th Annual Oncology Nursing Society Annual Congress to discuss the ongoing chemo shortage and how patients and care teams approached these challenges. Transcript: Particularly at Hartford HealthCare, when we established this infrastructure, our goal was to make sure that every patient would get the treatment that they need and require, utilizing the data that we have from ASCO guidelines to ensure that we're getting the optimal high-quality standard of care in a timely fashion that we didn't have to delay therapies. So, we were able to do that by going down to the minutiae of the milligrams on hand, particularly when we had a lot of critical drug shortages. So it was really creating that process to really ensure that every patient would get the treatment that they needed. For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.
Yuliya P.L Linhares, MD, an expert on CLL
Yuliya P.L Linhares, MD, and Josie Montegaard, MSN, AGPCNP-BC, experts on CLL
Image of a man with a beard.
Image of a man with gray facial hair and a navy blue suit with a light orange tie.
Image of a woman with black hair.
Related Content